A. Alolayan

Safety and efficacy of combined trans-arterial radioembolization and systemic therapy for advanced hepatocellular carcinoma

BackgroundThe current management of advanced hepatocellular carcinoma (HCC) is limited to systemic therapy alone. However the combination of trans-arterial radioembolization (TARE) and sy...

R. Madkhali ;

O. Bashir ;

K. Alshammari ;

A. Alolayan ;

M. Arabi ;

06/25/2023

Clinical characteristics and outcomes of patients with hepatocellular carcinoma treated at a large multidisciplinary clinic in Saudi Arabia

BackgroundHepatocellular carcinoma (HCC) is the fourth most common solid tumor affecting adult males in Saudi Arabia and the condition poses a serious health threat to patients affected. ...

M. Algarni ;

R. Alanazi ;

K. Alshammari ;

A. Alammar ;

A. Alrashdi ;

H. Alrajih ;

N. Algazlan ;

J. Altwalah ;

F. Alotaibi ;

H. Shehata ;

M. Alkaiyat ;

J. Al Qahtani ;

A. Alolayan ;

M. Arabi ;

06/25/2023

Safety and efficacy of short cetuximab infusion for patients with metastatic colorectal cancer

BackgroundCetuximab is an FDA approved anti-EGFR monoclonal antibody that is given to patients with metastatic colorectal cancer (mCRC) who are KRAS and NRAS wildtype (wt). Dosing of cetu...

K. Alshammari ;

F. Alotaibi ;

H. Shehata ;

M. Alkaiyat ;

J. Al Qahtani ;

A. Alolayan ;

M. Algarni ;

Mohamed M. Ali ;

A. Abushara ;

A. Al-Abdulaali ;

06/25/2023